Letter from CGS to members of the California Institute for Regenerative Medicine's Independent Citizens Oversight Committee
By Marcy Darnovsky
| 02. 02. 2005
Dear Members of the Independent Citizens Oversight Committee:
The California public has given you the responsibility to oversee
an enormous undertaking of great potential: the largest state-funded
research program in U.S. history. The Center for Genetics and
Society supports the public funding of embryonic stem cell research
but is concerned that the new California Institute for Regenerative
Medicine (CIRM) is off to a stumbling start with regard to public
transparency and accountability. Although these are not due
to explicit decisions by your committee, you are in a position
to remedy them.
There are three particularly troubling areas of concern.
Conflict of interest regulations. This week the National
Institutes of Health - in many ways a federal analogy to your
own enterprise - announced that it is significantly strengthening
its regulations to curtail conflicts of interest. This highlights
a growing awareness that the conduct and oversight of biomedical
research requires strict protections. Yet the ICOC is failing
to make this a priority. Although it is mandated to adopt standards
"initially based" on those of the NIH for its employees
and...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...